Twinbeech Capital LP Insulet Corp Transaction History

Twinbeech Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $4.42 Million - $5.65 Million	27,043 New	27,043 $4.64 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $28.6 Million - $53.9 Million	185,201 New	185,201 $29.5 Million
Q2 2022 Aug 15, 2022	SELL	$186.4 - $279.02 $850,729 - $1.27 Million	-4,564 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $2 Million - $2.83 Million	-10,274 Reduced 69.24%	4,564 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$255.32 - $318.29 $3.79 Million - $4.72 Million	14,838 New	14,838 $3.95 Million
Q3 2020 Nov 16, 2020	SELL	$192.55 - $236.59 $780,790 - $959,372	-4,055 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$159.17 - $224.73 $645,434 - $911,280	4,055 New	4,055 $788,000

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.